InsidersTradesSigma
IDL Diagnostics Stock: price and management transactions · Finland · FIN-FSA
Follow the IDL Diagnostics share price and the full management transaction log of the company, a publicly traded company based in Finland. Shares are quoted on FI FI, under the supervision of FIN-FSA. Operating in the Health Care sector, IDL Diagnostics has logged 2 public disclosures. Market capitalisation: €98.6m. The latest transaction was filed on 30 May 2026 (Purchase). Among the most active insiders: Eva Nordström. Every trade is accessible without an account.
2
Insider Decl.
n/a
Thresholds
€17,724
2 ops.
Buy Volume
n/a
n/a
Sell Volume
19Σ signal
Fundamental score
Ranked 24,700 of 28,169 companies
24.3
score / 100
Value15
Quality33
FCF yld-9.9%
Earn yld-13%
EV/EBITDA·
ROE-6.5%
Gross mgn52%
Net mgn-23%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 30 May 2026
Declarations2 total
200,000 shares@ SEK 0.480.0077% mcap50.0% of flowAktieFI:csv-bca539a5acff2105c54e
200,000 shares@ €0.0443100.0% of flowAktieFI:A003Z358-1
2 of 2 declarations
About IDL Diagnostics
IDL Diagnostics is a company focused on developing medical diagnostic solutions. It operates on the XSTO stock market.